Incubate Comments on the Initiation of a Section 301 Investigation Regarding Germany’sPersistent Underpayment for Innovative Pharmaceutical ProductsIncubate CoalitionAug 100 min readIncubate_USTR 301 Comment BP 2.pdfDownload PDF • 272KB
Incubate Comments on Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program Proposed Rule
Incubate Responds to Request for Information: Commonsense Policy Options to Lower Drug Prices for Patients
Comments